Protection of erythropoietin on experimental spinal cord injury by reducing the expression of thrombospondin-1 and transforming growth factor-β

被引:18
|
作者
Fang Xiang-qian [2 ]
Fang Mei
Fan Shun-wu [2 ]
Gu Chuan-long [1 ]
机构
[1] Zhejiang Univ, Dept Cell Biol & Anat, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China
[2] Zhejiang Univ, Dept Orthopaed, Sch Med, Sir Run Run Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China
关键词
thrombospondin-1; transforming growth factor-beta; spinal cord injury; erythropoietin; TGF-BETA; COLLAGEN; MODEL; RAT;
D O I
10.3760/cma.j.issn.0366-6999.2009.14.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Erythropoietin (EPO) functions as a tissue-protective cytokine in addition to its crucial hormonal role in red cell production and neuron protection. This study aimed to determine the neuron protective effect of erythropoietin on experimental rats enduring spinal cord injury (SCI) by assessing thrombospondin-1 (TSP-1) level and transforming growth factor-beta (TGF-beta) in the development of a rat model of SCI. Methods Sixty Sprague-Dawley rats were randomly assigned to three groups: sham operation control group, SCI group and EPO treatment group. By using a weight-drop contusion SCI model, the rats in the SCI group and EPO treatment group were sacrificed at 24 hours and 7 days subsequently. The Basso, Beattie, and Bresnahan (BBB) scores were examined for locomotor function. Pathological changes were observed after HE staining. The expressions of thrombospondin-2 (TSP-1) and TGF-beta were determined by immunohistochemical staining and Western blotting. Results Slighter locomotor dysfunction was discovered and it was recovered abruptly as higher BIBB scores were found in the EPO treatment group than in the SCI group (P<0.01). Pathologically, progressive disruption of the dorsal white matter and regeneration of a few neurons were also observed in SCI rats. TSP-1 and TGF-beta expression increased at 24 hours and 7 days after SCI in the injured segment, and it was higher in the SCI group than in the EPO treatment group. Spinal cord samples from the animals demonstrated a TSP-1 optical density of 112.2 +/- 6.8 and TSP-1 positive cells of 5.7 +/- 1.3 respectively. After injury, the TSP-1 optical density and cell number increased to 287.2 +/- 14.3/mm(2) and 23.2 +/- 2.6/mm(2) at 24 hours and to 232.1 +/- 13.2/mm(2) and 15.2 +/- 2.3/mm(2) at 7 days respectively. When EPO treated rats compared with the SCI rats, the TSP-1 optical density and cell number decreased to 213.1 +/- 11.6/mm(2) and 11.9 +/- 1.61mm(2) at 24 hours and to 189.9 +/- 10.5/mm(2) and 9.3 +/- 1.5/mm(2) at 7 days, respectively (P<0.01). In the SCI rats, the TGF-beta optical density and positive neuron number were 291.4 +/- 15.2/mm(2) and 28.8 +/- 4.9/mm(2) at 24 hours and 259.1 +/- 12.3/mm(2) and 23.9 +/- 4.1/mm(2) at 7 days respectively. They decreased in the EPO treated rats to 222.8 +/- 11.9/mm(2) and 13.7 +/- 2.1/mm(2) at 24 hours and to 196.5 +/- 9.7/mm(2) and 8.7 +/- 2.2/mm(2) at 7 days (P<0.01). Conclusions Increased expression of TSP-1 and TGF-beta can be found in the injured segment of the spinal cord at 24 hours and 7 days after injury. EPO treatment can effectively prevent pathological alterations from severe spinal cord injury by reduced expression of TSP-1 and TGF-beta. Chin Med J 2009;122(14):1631-1635
引用
收藏
页码:1631 / 1635
页数:5
相关论文
共 50 条
  • [21] Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-β-dependent and -independent mechanisms
    Miao, WM
    Seng, WL
    Duquette, M
    Lawler, P
    Laus, C
    Lawler, J
    CANCER RESEARCH, 2001, 61 (21) : 7830 - 7839
  • [22] Transient silencing of transforming growth factor-β1 expression restores nitric oxide generation in diabetic hematopoietic stem/progenitor cells: Role of thrombospondin-1
    Jahan, Jesmin
    Miguel, Duran
    Quiroz, Julio
    Gracia, Charles
    Bartelmez, Stephen
    Jarajapu, Yagna
    FASEB JOURNAL, 2020, 34
  • [23] Dynamic expression patterns of transforming growth factor-β2 and transforming growth factor-β receptors in experimental glomerulonephritis
    Andrea Hartner
    Karl F. Hilgers
    Markus Bitzer
    Roland Veelken
    Harald O. Schöcklmann
    Journal of Molecular Medicine, 2003, 81 : 32 - 42
  • [24] Curcumin protects against lipopolysaccharide-induced vasoconstriction dysfunction via inhibition of thrombospondin-1 and transforming growth factor-β1
    Lu, Wei
    Jiang, Jian-Ping
    Hu, Jue
    Wang, Jue
    Zheng, Ming-zhi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (02) : 377 - 383
  • [25] Dynamic expression patterns of transforming growth factor-β2 and transforming growth factor-β receptors in experimental glomerulonephritis
    Hartner, A
    Hilgers, KF
    Bitzer, M
    Veelken, R
    Schöcklmann, HO
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (01): : 32 - 42
  • [27] The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-β
    Ribeiro, SMF
    Poczatek, M
    Schultz-Cherry, S
    Villain, M
    Murphy-Ullrich, JE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) : 13586 - 13593
  • [28] ANDROGEN-SENSITIVE THROMBOSPONDIN-1 REGULATES PROSTATE EPITHELIAL PROLIFERATION AND TRANSFORMING GROWTH FACTOR-β ACTIVATION IN THE MOUSE PROSTATE
    Doll, Jennifer A.
    Lee, Chung
    Bergh, Anders
    Fitchev, Philip
    Cornwell, Mona
    Wcislak, Susan
    Crawford, Susan E.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 93 - 94
  • [29] Increased Cavernous Expression of Transforming Growth Factor-β1 and Activation of the Smad Signaling Pathway Affects Erectile Dysfunction in Men with Spinal Cord Injury
    Shin, Tae-Young
    Ryu, Ji-Kan
    Jin, Hai-Rong
    Piao, Shuguang
    Tumurbaatar, Munkhbayar
    Yin, Guo Nan
    Shin, Sun Hwa
    Kwon, Mi-Hye
    Song, Kang-Moon
    Fang, Zheng-Huan
    Han, Jee-Young
    Kim, Woo Jean
    Suh, Jun-Kyu
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (05): : 1454 - 1462
  • [30] Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma
    Maeda, K
    Nishiguchi, Y
    Yashiro, M
    Yamada, S
    Onoda, N
    Sawada, T
    Kang, SM
    Hirakawa, K
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 5 (04) : 373 - 378